COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

NCT06704516 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Menopause
Metabolic Dysfunction Associated Steatotic Liver Disease

Interventions

DRUG: Menopausal hormone therapy

Sponsor

University of Oxford

Collaborators

[object Object]